Biodesix, Inc.BDSXNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +34.54% | +39.28% | +21.19% | +11.68% | +19.93% |
| Gross Profit Growth | +36.15% | +42.44% | +22.43% | +13.80% | +26.41% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -90.82% | +58.79% | -92.46% | +15.32% | +2.53% |
| Weighted Average Shares Diluted Growth | -90.82% | +58.79% | -92.46% | +15.32% | +2.53% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +39.10% | +12.03% | -22.78% | -26.43% | +57.72% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +18.39% | -1.87% | -1.10% | -24.26% | -13.65% |
| Book Value per Share Growth | +0.00% | +187.05% | +0.00% | -97.28% | +0.00% |
| Debt Growth | +22.08% | +2.12% | +1.81% | +17.07% | +17.71% |
| R&D Expense Growth | +31.42% | +27.79% | +40.69% | +27.80% | +17.47% |
| SG&A Expenses Growth | +29.17% | +24.42% | -0.53% | +13.99% | +8.48% |